Celexa Related Published Studies
Well-designed clinical trials related to Celexa (Citalopram)
Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder. [2008.09]
Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study. [2008.08]
Effects of citalopram infusion on the serotonin transporter binding of [11C]DASB in healthy controls. [2008.08]
CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy. [2008.07]
Short-term intravenous citalopram augmentation in partial/nonresponders with major depression: a randomized placebo-controlled study. [2008.07]
Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy. [2008.06]
Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. [2008.05.28]
A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. [2008.05]
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. [2008.05]
Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. [2008.05]
Citalopram improves dexterity in chronic stroke patients. [2008.05]
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study. [2008.04.30]
Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder. [2008.04]
Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. [2008.04]
An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients. [2008.04]
Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. [2008.03]
Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase. [2008.03]
Citalopram neuropharmacological challenge in alcohol-dependent patients and controls: pharmacogenetic, endocrine and psychobehavioral results. [2008.03]
Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial. [2008.03]
Escitalopram in specific phobia: results of a placebo-controlled pilot trial. [2008.03]
Escitalopram effects on insula and amygdala BOLD activation during emotional processing. [2008.03]
Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. [2008.02.15]
CTN-194 (PICCO): Design of a trial of citalopram for the prevention of depression and its consequences in HIV-Hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy. [2008.01.12]
Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. [2008.01]
Escitalopram in the acute treatment of depressed patients aged 60 years or older. [2008.01]
Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial. [2008.01]
High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial. [2008.01]
Comparison of sertraline and citalopram for treatment of premature ejaculation. [2008.01]
An open-label trial of escitalopram in children and adolescents with social anxiety disorder. [2007.12]
A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. [2007.11]
Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: A 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. [2007.11]
Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. [2007.10]
Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial. [2007.10]
Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. [2007.10]
Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison. [2007.10]
Escitalopram in the treatment of obsessive-compulsive disorder: a double blind placebo control trial. [2007.10]
A Double-Blind Comparison of Citalopram and Risperidone for the Treatment of Behavioral and Psychotic Symptoms Associated With Dementia. [2007.09.10]
Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. [2007.08.27]
Predictors of Attrition During Initial (Citalopram) Treatment for Depression: A STAR*D Report. [2007.08]
Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. [2007.07]
Escitalopram prevents relapse in older patients with major depressive disorder. [2007.07]
A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder. [2007.07]
Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo. [2007.07]
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. [2007.07]
An open-label multicentric study of the tolerability and response to escitalopram treatment in Indian patients with major depressive disorder. [2007.07]
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. [2007.06]
Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial. [2007.05.15]
Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. [2007.05]
Pharmacokinetic comparison of two 40 mg tablet formulations of citalopram using a new amperometric detection technique. [2007.05]
Escitalopram prevents relapse of obsessive-compulsive disorder. [2007.05]
Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study. [2007.04]
Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study. [2007.04]
Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation. [2007.03]
Efficacy of citalopram on climacteric symptoms. [2007.03]
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. [2007.02]
Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. [2007.02]
Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers. [2007.02]
Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. [2007.01.24]
A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. [2007.01]
Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice. [2007]
The influence of educational information on depressed outpatients treated with escitalopram: A semi-naturalistic study. [2007]
Escitalopram in the treatment of anxiety symptoms associated with depression. [2007]
Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial. [2007]
Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder. [2007]
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram). [2007]
A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. [2006.12]
Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial. [2006.11]
S-Citalopram in neuroendocrine challenge-tests: serotonergic responsivity in healthy male and female human participants. [2006.11]
Neuroendocrine effects of citalopram infusion in anorexia nervosa. [2006.11]
Open-label trial of escitalopram in the treatment of posttraumatic stress disorder. [2006.10]
Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? [2006.10]
Prevention of relapse in generalized anxiety disorder by escitalopram treatment. [2006.10]
In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram. [2006.10]
Usefulness of serotoninergic challenge with oral citalopram. [2006.09]
Escitalopram versus venlafaxine XR in the treatment of depression. [2006.09]
Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study. [2006.09]
A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. [2006.08]
A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. [2006.07]
Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. [2006.07]
A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. [2006.06]
Effects of oral racemic citalopram on neuroendocrine responses. [2006.06]
Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial. [2006.05]
Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. [2006.05]
A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. [2006.05]
Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram. [2006.05]
Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder. [2006.04]
Outcomes of late-life anxiety disorders during 32 weeks of citalopram treatment. [2006.03]
Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study. [2006.03]
A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. [2006.03]
Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study. [2006.03]
Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study. [2006.02.01]
Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial. [2006.02]
Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE). [2006.01]
An Open Trial of Adjunctive Escitalopram in Bipolar Depression. [2006.01]
Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. [2006.01]
Escitalopram versus paroxetine for social anxiety disorder: An analysis of efficacy for different symptom dimensions. [2006.01]
Dose response to adjunctive light therapy in citalopram-treated patients with post-stroke depression. A randomised, double-blind pilot study. [2006]
Escitalopram in the long-term treatment of major depressive disorder in elderly patients. [2006]
A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study. [2005.12.01]
Does rTMS Hasten the Response to Escitalopram, Sertraline, or Venlafaxine in Patients With Major Depressive Disorder? A Double-Blind, Randomized, Sham-Controlled Trial. [2005.12]
The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects. [2005.12]
|
